Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm

NCT04638699 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2023-03-01

No results posted yet for this study

Summary

Adequate, needs-oriented psycho-oncological care contributes to reducing the burden on cancer patients and their relatives and to improving the quality of life. There is still a need for clarification regarding the need and the determination of psychosocial needs. This multi-center study (3 centers: Hanover, Leipzig and Dresden) aims at a professionalization of psychosocial screening, in order to enable thus an exact and need-based allocation to psycho-oncological support. The optimization and professionalization of the psychosocial screening process shall be achieved by a training of oncological nursing and development of an interdisciplinary care algorithm. The aim is to examine whether "OptiScreen" increases the targeted and needs-based allocation to psycho-oncology.

Conditions

  • Psycho-Oncology
  • Visceral Cancer
  • Screening
  • Psychosocial Stressor

Interventions

OTHER

OptiScreen training

Special psycho-oncological training for nursing staff to acquire basic knowledge about the experience of mental stress as well as diagnostics of psychosocial stress

Sponsors & Collaborators

  • Universitätsklinikum Leipzig

    collaborator OTHER
  • UniversitätsKrebsCentrum Dresden

    collaborator UNKNOWN
  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Tanja Zimmermann · Hannover Medical School

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638699 on ClinicalTrials.gov